Showing results (51-60 of 120) with videos related to
Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG projectPaola Angelini, Wendy B London, Susan L Cohn, et al.European Journal of Cancer (Oxford, England : 1990)|July 20, 2016
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group databaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group projectKieuhoa T Vo, Katherine K Matthay, John Neuhaus, et al.Journal of the National Cancer Institute|November 17, 2023
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug developmentAndrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.Pediatric Blood & Cancer|July 22, 2014
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group projectHolly J Meany, Wendy B London, Peter F Ambros, et al.Plos One|August 2, 2014
Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastomaNada M S Al-Saffar, Lynley V Marshall, L Elizabeth Jackson, et al.Nature Reviews. Clinical Oncology|May 17, 2017
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspectiveLucas Moreno, Andrew D J Pearson, Xavier Paoletti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of ageDenah R Taggart, Wendy B London, Mary Lou Schmidt, et al.Cancer Research|October 12, 2010
MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signatureNathalie Gaspar, Lynley Marshall, Lara Perryman, et al.Pediatric Blood & Cancer|August 25, 2016
Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trialsLucas Moreno, Herve Rubie, Amalia Varo, et al.Pageof 12